H-SP^SYAYHQF-OH

Ref. 3D-PP49086

Produktinformation

• Name: H-SP^SYAYHQF-OH

Beschreibung

Peptide H-SP^SYAYHQF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SP^SYAYHQF-OH include the following: Position-Scanning Peptide Libraries as Particle Immunogens for Improving CD8+ T-Cell Responses X He , S Zhou , B Quinn, WC Huang - Advanced , 2021 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/advs.202103023 Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment TH Kang, JH Park, A Yang , HJ Park, SE Lee - Nature , 2020 - nature.comhttps://www.nature.com/articles/s41467-020-14821-z TLR9 acts as a sensor for tumor-released DNA to modulate anti-tumor immunity after chemotherapy TH Kang, CP Mao, YS Kim, TW Kim, A Yang - for immunotherapy of , 2019 - Springerhttps://link.springer.com/article/10.1186/s40425-019-0738-2 Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity TH Kang, CP Mao, SY Lee , A Chen, JH Lee, TW Kim - Cancer research, 2013 - AACRhttps://aacrjournals.org/cancerres/article-abstract/73/8/2493/589526 A liposomal RNA vaccine inducing neoantigen-specific CD4+ T cells augments the antitumor activity of local radiotherapy in mice N Salomon, F Vascotto, A Selmi, M Vormehr - , 2020 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/2162402X.2020.1771925 Immunotherapy with Vaccinia virus co-expressing tumor-associated antigens and mouse IL-2 cytokine in mice with mammary cancer M Ye - 2022 - opus.bibliothek.uni-wuerzburg.dehttps://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/25309 Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade KA Pilones , M Hensler, C Daviaud, J Kraynak - , 2020 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/2162402X.2020.1830524 Radiotherapy cooperates with IL15 to induce antitumor immune responses KA Pilones , M Charpentier, E Garcia-Martinez - Cancer immunology , 2020 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/8/8/1054/470111 Integrin Targeting Enhances the Antimelanoma Effect of Annexin V in Mice J Zhu, X Li, W Gao, J Jing - International Journal of Molecular Sciences, 2023 - mdpi.comhttps://www.mdpi.com/1422-0067/24/4/3859 Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases F Oltmanns, AV Antaca£o, P Irrgang - for immunotherapy of , 2024 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10921546/ Controllable gelation of artificial extracellular matrix for altering mass transport and improving cancer therapies DW Zheng , S Hong, QL Zhang, X Dong, P Pan - Nature , 2020 - nature.comhttps://www.nature.com/articles/s41467-020-18493-7 Listeria-based cancer vaccines that segregate immunogenicity from toxicity DG Brockstedt, MA Giedlin, ML Leong - Proceedings of the , 2004 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0406035101 Enhancing the Generation of Eomeshi CD8+ T Cells Augments the Efficacy of OX40- and CTLA-4-Targeted Immunotherapy DA Emerson, AS Rolig , WL Redmond - Cancer Immunology Research, 2021 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/9/4/430/666173 The role of T cell cross-reactivity and IFNgamma in CD8+ T cell responses to a tumor-associated antigen CB Kemmler - 2011 - search.proquest.comhttps://search.proquest.com/openview/2d38ec3dfedbb1c9ff1eadb29bb57249/1?pq-origsite=gscholar&cbl=18750 Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control C Lhuillier, NP Rudqvist , T Yamazaki - The Journal of , 2021 - Am Soc Clin Investighttps://www.jci.org/articles/view/138740 Treating ischemia via recruitment of antigen-specific T cells BJ Kwee , BR Seo , AJ Najibi , AW Li, TY Shih - Science , 2019 - science.orghttps://www.science.org/doi/abs/10.1126/sciadv.aav6313

• Marke: Biosynth